Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
The chimeric endocrine receptor T-cell therapy of the company acts on the follicle stimulating hormone receptor.
Women's Health
Latest in
Women's Health
Iran is a leader in Phase III clinical trials in women’s health
Iran’s dominance in women’s health is spread comprehensively across indications, with more clinical trials than any other country.
By
The NHS acts to tackle the gender health gap in the UK
A strategy proposed by the DHSC sets bold ambitions to tackle deep-rooted, systemic issues within the UK’s healthcare system.
By
Pipeline Moves: Novartis suspends platform trial, advancement shot of four blood cancer assets drop
We also review primary systemic amyloidosis, tuberculosis, and uterine leiomyoma trial terminations.
By
Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
By
New biomarker could improve ovarian cancer diagnosis in younger women
A UK study published at the end of last month found that a new blood biomarker can improve the detection…
By
Evofem’s Phexxi shown to lower UTIs in women in Phase III trial
The adverse events reported in the trial were in line with the data from the overall trial results.
High exposure to PFAS more than doubles risk of developing diabetes in women
Study findings show an increased risk of diabetes due to exposure to perfluorinated or polyfluorinated alkyl substances (PFAS).
By